RSLS - Galectin Therapeutics ReShape Lifesciences leads healthcare gainers; Sigilon Therapeutics Aerpio Pharmaceuticals among major losers
Gainers: Galectin Therapeutics GALT +40%, ReShape Lifesciences (RSLS) +21%, INmune Bio (INMB) +17%, ASLAN Pharmaceuticals (ASLN) +15%, 89bio (ETNB) +14%.Losers: Sigilon Therapeutics SGTX -30%, Aerpio Pharmaceuticals (ARPO) -14%, Alterity Therapeutics (ATHE) -13%, OncoSec Medical (ONCS) -10%, GBS (GBS) -9%.
For further details see:
Galectin Therapeutics, ReShape Lifesciences leads healthcare gainers; Sigilon Therapeutics, Aerpio Pharmaceuticals among major losers